Immune-Mediated Hemolytic Anemia (IMHA) is a serious condition where the body's immune system attacks and destroys its own red blood cells, leading to severe anemia and various life-threatening complications. Here's an overview of the condition to help you understand the condition and how it affects your dog.
What Happens in IMHA
In IMHA, the immune system targets and destroys red blood cells, which are essential for carrying oxygen throughout the body.
- The immune system tags red blood cells with antibodies, leading to their removal from circulation and subsequent destruction.
- Destruction of red blood cells can occur within blood vessels (intravascular hemolysis) or outside of them (extravascular hemolysis).
- Excessive destruction of red blood cells leads to anemia, weakness, and other symptoms.
Symptoms of IMHA
- Weakness and lethargy.
- Lack of appetite and interest in food.
- Dark orange or brown urine.
- Pale gums and yellowing of tissues (jaundice).
- Fever.
Diagnostic Tests
Blood tests can reveal markers of red blood cell destruction, such as elevated bilirubin levels, spherocytes (abnormally shaped red blood cells), and positive Coombs test (detects antibodies on red blood cells).
Autoagglutination test detects clumping of red blood cells due to immune attack.
Complications of IMHA
- Excessive bilirubin production overwhelms the liver, causing jaundice.
- Hemoglobin released from destroyed red blood cells can damage the kidneys.
- Antibody-coated red blood cells clump together, forming clots that block blood vessels (thromboembolism), leading to tissue damage and inflammation.
- Thromboembolism is a leading cause of death in IMHA.
Treatment
- Immediate intervention is essential due to the severity of the condition.
- Blood transfusions may be required to address anemia.
- Immune-suppressive drugs, such as corticosteroids (e.g., prednisone) and azathioprine, are used to suppress the immune response and prevent further red blood cell destruction.
- Additional medications like cyclosporine or mycophenolate mofetil may be considered for more severe cases.
- Supportive care, including fluid balance maintenance and nutrition, is crucial.
Prognosis
- Mortality rates for IMHA range from 20% to 80%, depending on the study and severity of the case.
- Relapses can occur in 11-15% of cases.
- Long-term management may involve continued use of low-dose steroids to prevent recurrence.
Underlying Causes
- In many cases, no specific cause for IMHA is identified.
- Certain breeds, such as Cocker Spaniels and Poodles, may be predisposed.
- In cats, IMHA may be linked to feline leukemia virus infection or Mycoplasma hemofelis infection.
Preventing Thromboembolic Disease
- Thromboembolic disease is a significant complication of IMHA.
- Anticoagulant therapy (e.g., heparin) may be used to prevent blood clot formation.
- Aspirin or clopidogrel may be considered for platelet inhibition.
IMHA is a complex and serious condition that requires prompt and aggressive treatment. Immune-suppressive drugs, blood transfusions, and supportive care are crucial components of managing this potentially life-threatening disease. The prognosis varies and depends on the severity of the case and the response to treatment.
Don't have a vet in your area yet? We can help you find a local veterinarian.
If you have more questions, the GeniusVets Telehealth platform will give you unlimited access to text and/or video calls with board-certified veterinarians! To learn more click here.